Insmed Inc reports results for the quarter ended June 30 - Earnings Summary

Insmed Incorporated

06/08/2026 14:32

Insmed Inc INSM.OQ reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.70.  The mean expectation of nineteen analysts for the quarter was for a loss of 78 cents per share. Wall Street expected results to range from $-1.35 to -45 cents per share.
Revenue rose 296.1% to $425.49 million from a year ago; analysts expected $392.84 million. 
Insmed Inc's reported EPS for the quarter was a loss of 6 cents​.
The company reported a quarterly loss of $13.24 million.
Insmed Inc shares had fallen by 7.1% this quarter and lost 43.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 1.1% in the last three months.​ 
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 24 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Insmed Inc is $198.11, about 50% above its last closing price of $99.02
This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.78
-0.06
Beat
Mar. 31 2026 
-0.96
-0.76
Beat
Dec. 31 2025 
-1.29
-1.54
Missed
Sep. 30 2025 
-1.34
-1.75
Missed